Clinical Trial

CAR-T vs. Auto-SCT: Which Works Better for New Myeloma Patients?

Study acronym: ASCTvsCAR-T
Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated July 17, 2025 (before its estimated July 15, 2026 completion). Its status may not reflect the trial's current state.
Summary
This is a prospective study comparing anti-BCMA CAR-T to autologous hematopoietic stem cell transplantation alone in the treatment of newly diagnosed multiple myeloma patients.
Trial Details
NCT Number NCT07070934
Lead Sponsor Xuzhou Medical University
Conditions Multiple Myeloma, Newly Diagnosed
Enrollment 60 participants
Start Date 2025-07-15
Primary Completion 2026-07-15 (estimated)
Study Completion 2028-07-31 (estimated)
Updated on ClinicalTrials.gov 2025-07-17